Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Potential Disease-Modifying Activity of Navtemadlin (KRT-232), a First-in-Class MDM2 Inhibitor, Correlates with Clinical Benefits in Relapsed/Refractory Myelofibrosis (MF)

Pankit Vachani, Andrzej Lange, Regina Garcia Delgado, Haifa Kathrin Al-Ali, Jesus Maria Hernández-Rivas, Jean-Jacques Kiladjian, Alessandro Vannucchi, Andrew Charles Perkins, Venu Valmeekam, Cecile Marie Krejsa, Anne Uyei, Jesse McGreivy, Wayne P. Rothbaum, John Mascarenhas, Srdan Verstovsek

Blood (2021) 138 (Supplement 1): 3581.

https://doi.org/10.1182/blood-2021-147543

Published: 2021

Journal Articles

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Marta Lemieszewska, Agnieszka Tarnowska, Helena Pakos, Anna Sobczynska-Konefal, Andrzej Lange, MD

Blood (2019) 134 (Supplement_1): 5164.

https://doi.org/10.1182/blood-2019-130316

Published: 2019

Journal Articles

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Blood (2019) 134 (Supplement_1): 44.

https://doi.org/10.1182/blood-2019-124644

Published: 2019

Journal Articles

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Emilia Jaskula, Andrzej Lange, MD, Mariola Sedzimirska, Jakub Chrustowicz, Agnieszka Tarnowska, Janusz Lange

Blood (2017) 130 (Supplement 1): 1420.

https://doi.org/10.1182/blood.V130.Suppl_1.1420.1420

Published: 2017

Journal Articles

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Andrzej Lange, MD FRCP, Dr MDSci, Professor, Monika Mordak-Domagala, MD, Mariola Sedzimirska, MD PhD, Michalina Krydel, Helena Pakos, Jolanta Bochenska, Emilia Jaskula, PhD

Blood (2016) 128 (22): 5763.

https://doi.org/10.1182/blood.V128.22.5763.5763

Published: 2016

Journal Articles

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Blood (2014) 124 (21): 2564.

https://doi.org/10.1182/blood.V124.21.2564.2564

Published: 2014

Journal Articles

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Emilia Jaskula, PhD, Janusz Lange, MD PhD, Mariola Sedzimirska, MD PhD, Andrzej Lange, MD Dr MDSci., Professor

Blood (2014) 124 (21): 5265.

https://doi.org/10.1182/blood.V124.21.5265.5265

Published: 2014

Journal Articles

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

Mariola Sedzimirska, MD, PhD, Aleksandra Klimczak, PhD, Emilia Jaskula, PhD, Dlubek Dorota, PhD, Andrzej Lange, MD, PhD

Blood (2013) 122 (21): 5261.

https://doi.org/10.1182/blood.V122.21.5261.5261

Published: 2013

Journal Articles

Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation

Andrzej Lange, MD, DSci, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Przemyslaw Czajka, MSci, Janusz Lange, MD, Monika Mordak, MD, Dorota Dlubek, PhD

Blood (2012) 120 (21): 4487.

https://doi.org/10.1182/blood.V120.21.4487.4487

Published: 2012

Journal Articles

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Blood (2012) 120 (21): 3602.

https://doi.org/10.1182/blood.V120.21.3602.3602

Published: 2012

Journal Articles

IL-17 Positive Lymphocytes Predominantly Home At the Mucous Than in the Skin in cGvHD Patients

Aleksandra Klimczak, PhD, Krzysztof Suchnicki, PhD, Andrzej Lange, MD, DSci

Blood (2011) 118 (21): 3053.

https://doi.org/10.1182/blood.V118.21.3053.3053

Published: 2011

Journal Articles

Selective Accumulation of CD45RO+CCR7- in the Marrow Aspirates in Patients with Essential Thrombocythemia

Andrzej Lange, Mariola Sedzimirska, MD, Aleksandra Klimczak, Daria Drabczak Skrzypek

Blood (2011) 118 (21): 5155.

https://doi.org/10.1182/blood.V118.21.5155.5155

Published: 2011

Journal Articles

Low Blood Levels of Th17 Cells Are Seen in Patients with aGvHD and Associate with Rather Poor Survival Post HSCT,

Andrzej Lange, MD, DSci, Krzysztof Suchniski, MD, PhD, Sylwia Mizia, MSci, Przemyslaw Czajka, Lach Antonina, MSci, Dlubek Dorota, PhD

Blood (2011) 118 (21): 4079.

https://doi.org/10.1182/blood.V118.21.4079.4079

Published: 2011

Journal Articles

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

Andrzej Lange, MD, DSci, Emilia Jaskula, PhD, Sylwia Mizia, MSci, Jolanta Bochenska, MSci, Janusz Lange, MD

Blood (2011) 118 (21): 4552.

https://doi.org/10.1182/blood.V118.21.4552.4552

Published: 2011

Journal Articles

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

Grzegorz Mazur, Emilia Jaskula, Ilona Kryczek, Dorota Dlubek, Tomasz Wrobel, MD, PhD, Aleksandra Butrym, Andrzej Lange, MD, Kazimierz Kuliczkowski

Blood (2010) 116 (21): 3103.

https://doi.org/10.1182/blood.V116.21.3103.3103

Published: 2010

Journal Articles

Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.

Blood (2010) 116 (21): 1067.

https://doi.org/10.1182/blood.V116.21.1067.1067

Published: 2010

Journal Articles

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

Janusz Lange, MD, Daria Drabczak-Skrzypek, Dorota Dlubek, Emilia Jaskula, Dariusz Wolowiec, Andrzej Lange, MD

Blood (2010) 116 (21): 4555.

https://doi.org/10.1182/blood.V116.21.4555.4555

Published: 2010

Journal Articles

MARROW of Essential Thrombocythemia PATIENTS IS ENRICHED IN Effector Memory CD4+ and CD4+CD25++ Lymphocytes as Compared to BLOOD

Mariola Sedzimirska, MD, Daria Drabczak-Skrzypek, Andrzej Lange, MD

Blood (2010) 116 (21): 5058.

https://doi.org/10.1182/blood.V116.21.5058.5058

Published: 2010

Journal Articles

TH17 CD4+ CELLS Disappear FROM BLOOD at the Onset of aGVHD

Andrzej Lange, MD, Antonina Lach, Wojtowicz Agnieszka, Daria Drabczak-Skrzypek, Dlubek Dorota

Blood (2010) 116 (21): 2307.

https://doi.org/10.1182/blood.V116.21.2307.2307

Published: 2010

Journal Articles

Proportion of IL-17A Producing CD4+ Cells Increases in Response to Alloreactivity as Part of a Network Involving Memory and Regulatory Cells Post HSCT.

Andrzej Lange, MD, PhD, Dorota Dlubek, PhD, Krzysztof Suchnicki, Sylwia Madej, Eliza Turlej

Blood (2009) 114 (22): 1160.

https://doi.org/10.1182/blood.V114.22.1160.1160

Published: 2009

NARROW

Potential Disease-Modifying Activity of Navtemadlin (KRT-232), a First-in-Class MDM2 Inhibitor, Correlates with Clinical Benefits in Relapsed/Refractory Myelofibrosis (MF)

Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

Intra Bone Route of Donor Lymphocyte Infusions May Result with an Anti-Leukemic Effect Associated with an Accumulation of CD279+ Lymphocytes in the Marrow

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Sorafenib Is Contributing to Salvage Chemotherapy and Is Effective Given Alone for Maintenance in AML FLT3 ITD Patients Relapsing Post Allo Hematopoietic Stem Cell Transplantation

Essential Thrombocytosis Patients Have At Diagnosis Prevalence Of CD8+ and CD45RO+CCR7- Lymphocytes and High Proportions Of Double Positive IL-17+/CD15+ Cells In The Marrow Cell Population

Th17 Cells Blood Proportions Are Influenced by Factors Associated with CRP Serum Level Increase and with NOD2/CARD15 Gene Mutation

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

IL-17 Positive Lymphocytes Predominantly Home At the Mucous Than in the Skin in cGvHD Patients

Selective Accumulation of CD45RO+CCR7- in the Marrow Aspirates in Patients with Essential Thrombocythemia

Low Blood Levels of Th17 Cells Are Seen in Patients with aGvHD and Associate with Rather Poor Survival Post HSCT,

CMV and EBV Reactivation Post HSCT Impairs Survival of Patients If They Do Not Produce IgM Antibodies Againts These Viruses

Gene Expression for Chemokine Receptors Influences Survival of Non-Hodgkin Lymphoma Patients

Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.

HSCT PATIENTS with HHV6 Reactivation HAD LOW NUMBERS of CD4+ Effector Memory Lymphocytes IN BLOOD WHAT Associates with Rather POOR SURVIVAL.

MARROW of Essential Thrombocythemia PATIENTS IS ENRICHED IN Effector Memory CD4+ and CD4+CD25++ Lymphocytes as Compared to BLOOD

TH17 CD4+ CELLS Disappear FROM BLOOD at the Onset of aGVHD

Proportion of IL-17A Producing CD4+ Cells Increases in Response to Alloreactivity as Part of a Network Involving Memory and Regulatory Cells Post HSCT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only